ARWR (STOCKS)
Arrowhead Research Corporation
$63.790000
-1.350000 (-2.07%)
Prev close: $65.140000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Christopher Richard Anzalone
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8,931.25M
- Employees
- 609
- P/E (TTM)
- 42.35
- P/B (TTM)
- 15.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.09B |
| Benefits Costs and Expenses | $836.06M |
| Costs And Expenses | $836.06M |
| Nonoperating Income/Loss | -$45.65M |
| Operating Expenses | $790.41M |
| Depreciation and Amortization | $25.08M |
| Research and Development | $647.36M |
| Other Operating Expenses | $117.97M |
| Operating Income/Loss | $300.57M |
| Income/Loss From Continuing Operations After Tax | $233.57M |
| Income/Loss From Continuing Operations Before Tax | $254.92M |
| Income Tax Expense/Benefit | $21.35M |
| Net Income/Loss | $233.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | $31.31M |
| Net Income/Loss Attributable To Parent | $202.27M |
| Net Income/Loss Available To Common Stockholders, Basic | $199.68M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.56 |
| Diluted Earnings Per Share | $1.53 |
| Basic Average Shares | 410,814,000 |
| Diluted Average Shares | 414,635,000 |
| Assets | $1.60B |
| Current Assets | $1.17B |
| Prepaid Expenses | $16.05M |
| Other Current Assets | $1.16B |
| Noncurrent Assets | $429.79M |
| Fixed Assets | $378.58M |
| Other Non-current Assets | $51.21M |
| Liabilities | $1.04B |
| Current Liabilities | $347.43M |
| Accounts Payable | $32.94M |
| Wages | $14.27M |
| Other Current Liabilities | $300.22M |
| Noncurrent Liabilities | $694.06M |
| Equity | $562.70M |
| Equity Attributable To Noncontrolling Interest | -$5.73M |
| Equity Attributable To Parent | $568.42M |
| Liabilities And Equity | $1.60B |
| Net Cash Flow From Operating Activities | $339.31M |
| Net Cash Flow From Operating Activities, Continuing | $339.31M |
| Net Cash Flow From Investing Activities | -$229.95M |
| Net Cash Flow From Investing Activities, Continuing | -$229.95M |
| Net Cash Flow From Financing Activities | $38.62M |
| Net Cash Flow From Financing Activities, Continuing | $38.62M |
| Exchange Gains/Losses | -$227.00K |
| Net Cash Flow | $147.75M |
| Net Cash Flow, Continuing | $147.98M |
| Comprehensive Income/Loss | $236.14M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $29.18M |
| Comprehensive Income/Loss Attributable To Parent | $206.71M |
| Other Comprehensive Income/Loss | $2.31M |